TIAA-CREF Individual & Institutional Services’s NovoCure NVCR Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$132K	Buy	+8,277	New	+$138K	﹤0.01%	747

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's NVCR Position: Q3 2026 in Review

TIAA-CREF Individual & Institutional Services opened a new position in NovoCure (NVCR) in Q3 2026: 8,277 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #747 among its holdings.

183 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

TIAA-CREF Individual & Institutional Services held 8,277 shares of NovoCure worth $132K as of Q3 2026.
NovoCure was a new TIAA-CREF Individual & Institutional Services position in Q3 2026.
NovoCure made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q3 2026, its #747 holding.
183 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q3 2026, filed 12 Nov 2026.